The Gemcitabine Market is influenced by healthcare reimbursement policies and hospital procurement practices. Pricing arrangements, formulary decisions, and budget constraints can affect the selection and availability of chemotherapy medicines across different healthcare systems. The Gemcitabine Market size is expected to reach US$ 1,370.48 million by 2034 from US$ 865.06 million in 2025,...